Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Emmessar Biotech & Nutrition Ltd · Outcome · 31 Oct 2026, 9:25 pm
Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 10.9 (+19.1% YoY | +84.1% QoQ) ■ EBITDA: -32.0 (+14.2% YoY | +9.4% QoQ) ■ EBITDA Margin (%): -293 (+11369 bps YoY | +30208 bps QoQ) ■ PAT: 14.0 (+23.1% YoY | +6.7% QoQ) ■ EPS (INR): 0.28 (+21.7% YoY | +7.7% QoQ) Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) Segmental Performance Healthcare ■ Revenue: 10.9 (+19.1% YoY | +84.1% QoQ) ■ EBIT: 7.1 (+5.0% YoY | +72.3% QoQ) ■ EBIT Margin (%): 64.8 (-867 bps YoY | -447 bps QoQ) Rent on leasehold land ■ Revenue: 41.3 (+0.0% YoY | +0.0% QoQ) ■ EBIT: 41.1 (+0.0% YoY | +0.0% QoQ) ■ EBIT Margin (%): 99.4 (+0 bps YoY | +0 bps QoQ) Others ■ Revenue: 10.3 (-18.3% YoY | -18.6% QoQ) ■ EBIT: 10.3 (-18.3% YoY | -18.6% QoQ) ■ EBIT Margin (%): 100 (+0 bps YoY | +0 bps QoQ)
Original exchange filing (PDF)
More announcements from Emmessar Biotech & Nutrition Ltd
- please refer attachment · 02 Nov 2026
- Please refer attachment · 31 Oct 2026
- Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please refer attachment · 31 Oct 2026
- Please refer attachment · 02 Oct 2026
- Please refer attachement · 29 Sept 2026
- Please refer attachment · 29 Sept 2026
- Please refer attachment · 05 Sept 2026
- Please refer attachment · 04 Sept 2026
